Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits

Cerebral Cortex

Volumn 21, Issue 3, 2011, Pages 574-587

  Wang, Doris D ^a,b   Kriegstein, Arnold R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXYL 5 METHYL 4 ISOXAZOLE PROPIONATE; BUMETANIDE; PROPIONIC ACID; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL STRUCTURE; DRUG ACTIVITY; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SENSORIMOTOR CORTEX; STARTLE REFLEX; SYNAPTIC TRANSMISSION;

ANIMALS; BUMETANIDE; CEREBRAL CORTEX; EXCITATORY POSTSYNAPTIC POTENTIALS; GAMMA-AMINOBUTYRIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; MICE; NEUROGENESIS; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; SEIZURES; SENSORY GATING; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; SYNAPTIC TRANSMISSION;

EID: 79951846694     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhq124     Document Type: Article

References (60)

1. Akerman CJ, Cline HT. 2006. Depolarizing GABAergic conductances regulate the balance of excitation to inhibition in the developing retinotectal circuit in vivo. J Neurosci. 26:5117-5130. (Pubitemid 44315293)
2. Bast T, Feldon J. 2003. Hippocampal modulation of sensorimotor processes. Prog Neurobiol. 70:319-345. (Pubitemid 37107357)
3. Ben-Ari Y. 2006. Basic developmental rules and their implications for epilepsy in the immature brain. Epileptic Disord. 8:91-102. (Pubitemid 44013151)
4. Ben-Ari Y, Holmes GL. 2005. The multiple facets of gamma-aminobutyric acid dysfunction in epilepsy. Curr Opin Neurol. 18:141-145. (Pubitemid 40477489)
5. Boettger T, Rust MB, Maier H, Seidenbecher T, Schweizer M, Keating DJ, Faulhaber J, Ehmke H, Pfeffer C, Scheel O, et al. 2003. Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. Embo J. 22:5422-5434. (Pubitemid 37279952)
6. Braff DL, Geyer MA, Swerdlow NR. 2001. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 156:234-258. (Pubitemid 32705488)
7. Cancedda L, Fiumelli H, Chen K, Poo MM. 2007. Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo. J Neurosci. 27:5224-5235. (Pubitemid 46741781)
8. Casanova MF, Buxhoeveden D, Gomez J. 2003. Disruption in the inhibitory architecture of the cell minicolumn: implications for autisim. Neuroscientist. 9:496-507. (Pubitemid 37474179)
9. Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puolivali J, Lesne S, Ashe KH, Muchowski PJ, et al. 2007. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem. 282: 23818-23828. (Pubitemid 47328006)
10. Cohen I, Navarro V, Clemenceau S, Baulac M, Miles R. 2002. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science. 298:1418-1421. (Pubitemid 35346141)
11. Curzon P, Decker MW. 1998. Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice. Prog Neuro-psychopharmacol Biol Psychiatry. 22:129-146. (Pubitemid 28096433)
12. Dawson GR, Tricklebank MD. 1995. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci. 16:33-36.
13. Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE, Staley KJ. 2005. NKCC1 transporter facilitates seizures in the developing brain. Nature Med. 11:1205-1213. (Pubitemid 43093668)
14. Esposito L, Raber J, Kekonius L, Yan F, Yu GQ, Bien-Ly N, Puolivali J, Scearce-Levie K, Masliah E, Mucke L. 2006. Reduction in mitochon-drial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci. 26: 5167-5179. (Pubitemid 44315298)
15. Geyer MA, McIlwain KL, Paylor R. 2002. Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry. 7: 1039-1053. (Pubitemid 36044262)
16. Graham IR, Chambers A. 1997. Constitutive expression vectors: PGK. Methods Mol Biol. 62:159-169.
17. Haas K, Li J, Cline HT. 2006. AMPA receptors regulate experience-dependent dendritic arbor growth in vivo. Proc Natl Acad Sci USA. 103:12127-12131. (Pubitemid 44215822)
18. Hennou S, Khalilov I, Diabira D, Ben-Ari Y, Gozlan H. 2002. Early sequential formation of functional GABA(A) and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus. Eur J Neurosci. 16:197-208. (Pubitemid 36160240)
19. Hensch TK. 2005. Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 6:877-888. (Pubitemid 41568729)
20. Hensch TK, Fagiolini M. 2005. Excitatory-inhibitory balance and critical period plasticity in developing visual cortex. Prog Brain Res. 147:115-124.
21. Jentsch JD, Roth RH. 1999. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 20: 201-225. (Pubitemid 29067401)
22. Kahle KT, Staley KJ. 2008. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Neurosurg Focus. 25:E22.
23. Kilb W, Sinning A, Luhmann HJ. 2007. Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse. Neuropharmacology. 53:524-533. (Pubitemid 47284187)
24. Lanska MJ, Lanska DJ, Baumann RJ. 1995. A population-based study of neonatal seizures in Fayette County, Kentucky: comparison of ascertainment using different health data systems. Neuroepidemi-ology. 14:278-285.
25. Li B, Woo RS, Mei L, Malinow R. 2007. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron. 54:583-597. (Pubitemid 46756136)
26. Li H, Tornberg J, Kaila K, Airaksinen MS, Rivera C. 2002. Patterns of cation-chloride cotransporter expression during embryonic rodent CNS development. Eur J Neurosci. 16:2358-2370. (Pubitemid 36056960)
27. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA. 2008. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31:234-242.
28. Moser D, Ekawardhani S, Kumsta R, Palmason H, Bock C, Athanassiadou Z, Lesch KP, Meyer J. 2008. Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional DNA methylation site. Neuro-psychopharmacology. 34:458-467.
29. Mukai J, Dhilla A, Drew LJ, Stark KL, Cao L, MacDermott AB, Karayiorgou M, Gogos JA. 2008. Palmitoylation-dependent neuro-developmental deficits in a mouse model of 22q11 microdeletion. Nat Neurosci. 11:1302-1310.
30. Noctor SC, Flint AC, Weissman TA, Dammerman RS, Kriegstein AR. 2001. Neurons derived from radial glial cells establish radial units in neocortex. Nature. 409:714-720. (Pubitemid 32144516)
31. Noctor SC, Martinez-Cerdeno V, Ivic L, Kriegstein AR. 2004. Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nat Neurosci. 7:136-144. (Pubitemid 38129789)
32. Nordstrom EJ, Burton FH. 2002. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry. 7:617-625.
33. Owens DF, Boyce LH, Davis MB, Kriegstein AR. 1996. Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J Neurosci. 16:6414-6423. (Pubitemid 26337365)
34. Owens DF, Kriegstein AR. 2002. Is there more to GABA than synaptic inhibition? Nat Rev. 3:715-727. (Pubitemid 135706677)
35. Owens DF, Liu X, Kriegstein AR. 1999. Changing properties of GABA(A) receptor-mediated signaling during early neocortical development. J Neurophysiol. 82:570-583. (Pubitemid 29387834)
36. Painter MJ, Scher MS, Stein AD, Armatti S, Wang Z, Gardiner JC, Paneth N, Minnigh B, Alvin J. 1999. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 341:485-489. (Pubitemid 29372888)
37. Palma E, Amici M, Sobrero F, Spinelli G, Di Angelantonio S, Ragozzino D, Mascia A, Scoppetta C, Esposito V, Miledi R, et al. 2006. Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory. Proc Natl Acad Sci USA. 103:8465-8468. (Pubitemid 43838478)
38. Pfeffer CK, Stein V, Keating DJ, Maier H, Rinke I, Rudhard Y, Hentschke M, Rune GM, Jentsch TJ, Hubner CA. 2009. NKCC1-dependent GABAergic excitation drives synaptic network maturation during early hippocampal development. J Neurosci. 29: 3419-3430.
39. Plotkin MD, Snyder EY, Hebert SC, Delpire E. 1997. Expression of the Na-K-2Cl cotransporter is developmentally regulated in postnatal rat brains: a possible mechanism underlying GABA's excitatory role in immature brain. J Neurobiol. 33:781-795. (Pubitemid 27465584)
40. Pond BB, Berglund K, Kuner T, Feng G, Augustine GJ, Schwartz-Bloom RD. 2006. The chloride transporter Na(+)-K(+)-Cl- cotrans-porter isoform-1 contributes to intracellular chloride increases after in vitro ischemia. J Neurosci. 26:1396-1406. (Pubitemid 43237010)
41. Rajan I, Cline HT. 1998. Glutamate receptor activity is required for normal development of tectal cell dendrites in vivo. J Neurosci. 18:7836-7846. (Pubitemid 28441023)
42. Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, Lamsa K, Pirvola U, Saarma M, Kaila K. 1999. The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature. 397:251-255.
43. Ronen GM, Penney S, Andrews W. 1999. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr. 134:71-75. (Pubitemid 29048682)
44. Saito T, Nakatsuji N. 2001. Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev Biol. 240: 237-246. (Pubitemid 33141120)
45. Saliba RM, Annegers JF, Waller DK, Tyson JE, Mizrahi EM. 1999. Incidence of neonatal seizures in Harris County, Texas, 1992-1994. Am J Epidemiol. 150:763-769. (Pubitemid 29463202)
46. Scearce-Levie K, Roberson ED, Gerstein H, Cholfin JA, Mandiyan VS, Shah NM, Rubenstein JL, Mucke L. 2008. Abnormal social behaviors in mice lacking Fgf17. Genes Brain Behav. 7:344-354. (Pubitemid 351490238)
47. Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K, Malinow R. 1999. Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science. 284:1811-1816.
48. Swerdlow NR, Geyer MA, Braff DL. 2001. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl). 156:194-215. (Pubitemid 32702213)
49. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA. 2000. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci. 20:4325-4336. (Pubitemid 30365703)
50. Tornberg J, Voikar V, Savilahti H, Rauvala H, Airaksinen MS. 2005. Behavioural phenotypes of hypomorphic KCC2-deficient mice. Eur J Neurosci. 21:1327-1337. (Pubitemid 40516631)
51. Treiman DM. 2001. GABAergic mechanisms in epilepsy. Epilepsia. (Suppl 42)3:8-12. (Pubitemid 32781374)
52. Tyzio R, Represa A, Jorquera I, Ben-Ari Y, Gozlan H, Aniksztejn L. 1999. The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite. J Neurosci. 19:10372-10382. (Pubitemid 30228044)
53. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, et al. 2008. Rare structural variants disrupt multiple genes in neuro-developmental pathways in schizophrenia. Science. 320:539-543. (Pubitemid 351590668)
54. Wang C, Shimizu-Okabe C, Watanabe K, Okabe A, Matsuzaki H, Ogawa T, Mori N, Fukuda A, Sato K. 2002. Developmental changes in KCC1, KCC2, and NKCC1 mRNA expressions in the rat brain. Brain Res. 139:59-66. (Pubitemid 35284680)
55. Wang DD, Kriegstein AR. 2008. GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. J Neurosci. 28:5547-5558.
56. Wang DD, Kriegstein AR. 2009. Defining the role of GABA in cortical development. J Physiol. 587:1873-1879.
57. Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson RM, Hefner K, Sprengel R, Celikel T, Daws LC, Holmes A. 2008. Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopami-nergia and 'schizophrenia-related' behaviors. Mol Psychiatry. 13:631-640. (Pubitemid 351704934)
58. Woo NS, Lu J, England R, McClellan R, Dufour S, Mount DB, Deutch AY, Lovinger DM, Delpire E. 2002. Hyperexcitability and epilepsy associated with disruption of the mouse neuronal-specific K-Cl cotransporter gene. Hippocampus. 12:258-268. (Pubitemid 34436708)
59. Wu GY, Cline HT. 1998. Stabilization of dendritic arbor structure in vivo by CaMKII. Science. 279:222-226. (Pubitemid 28103879)
60. Zavitsanou K, Nguyen V, Newell K, Ballantyne P, Huang XF. 2008. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia. J Chem Neuroanat. 36:71-76.